Date: 18 December 2020
General practitioners (GPs) play a vital role in the effective delivery of preventive care. GPs are uniquely placed to identify and test those at higher risk, provide information and encouragement to patients, and guide the coordination of treatment.
GPs play a key role in the National Bowel Cancer Screening Program, and have successfully participated in the program since its inception. Evidence has shown there is an increase in participation rates of a screening program when it is recommended by the GP.
The RACGP’s response to the National Bowel Cancer Screening Program Review highlights the main issues and challenges relating to participation, compliance and engagement with the screening program, and addresses the equity challenges of the program.